Day 2 #ccfobesitysummit24 Jaime Almandoz giving practical clinical tips on AOMs OTHER than GLP-1RA The Obesity Society Obesity Medicine Association OAC Cleveland Clinic MD

Another great talk by Dr Aminian #ccfobesitysummit24 Discussing cardiometabolic benefits as well as the heterogeneity of metabolic and bariatric surgery ASMBS ASMBS IH The Obesity Society Obesity Medicine Association Cleveland Clinic MD

Where are we with the use of AI in obesity care? Matthew Kroh, MD enlightens us on where the future lies Cleveland Clinic MD ASMBS ASGE GI Endoscopy The Obesity Society

ObesityLIVE Thursday, 11/14, 5-6p ET. “ All Hands on Deck: Multidisciplinary Management of End-Stage Obesity" Presented by: Dr. Stephen Firkins, Cleveland Clinic Meeting Link: bit.ly/ObesityLIVEmee… Register: bit.ly/OBESITYLIVE Ricard Corcelles MD W. Scott Butsch, MD MSc Roberto Simons-Linares, MD

Join us ! The Obesity Society Obesity Medicine Association ASMBS IH ASMBS American Board of Obesity Medicine Ali Aminian Beverly G. Tchang, MD Michael Albert, MD Cleveland Clinic MD

They doubted us.. still here. 🎞️ Produced by Cinema Sports #BillsMafia

Dr Silvana Pannain is presenting tonight at #ObesityLIVE

Kids from a Buffalo Children’s Hospital made an MVP video for their friend Josh Allen Easily the most wholesome thing you’ll see today

A new comprehensive review of GIP action from Professors Timo Müller and Matthias Tschöp et al, from discovery to modern day GIP-enabled medicines. Free to read via Molecular Metabolism #diabetes #obesity #islets #weightloss #incretin sciencedirect.com/science/articl… Helmholtz Munich | @HelmholtzMunich

Join us #obesityLIVE at 5pm ET

Does a Semaglutide first strategy before MBS lead to more weight loss compared to MBS alone ? Eric Sheu led a research team from Brigham and Women’s Department of Surgery to study a marched cohort of >350 patients after MBS 👇 JAMA Surgery Vasundhara Mathur MBBS Tom Shin, MD PhD jamanetwork.com/journals/jamas… Image

🧬 NEW STUDY: Obesity’s Massive Health Impact--from my research group, led by the brilliant Jackie Yao. - - - 🚨 In a nationwide study of 270,000+ adults using the All of Us Research Program, obesity was linked to a higher risk of 16 health conditions—with risk increasing by

Tune in Apr 23 – LIVE from Cleveland Clinic: OBESITY MGMT IN IBD. Join Florian Rieder Katie Falloon Norma Atkinson W. Scott Butsch, MD MSc Manuel Braga Neto MD, PhD Joseph Sleiman, MD, FACP Chelsea Feng Cleveland Clinic MD for this CME MOC event.  Register bit.ly/LIVECC2025

🌟 New research to be presented at #ECO2025 in Malaga, Spain, 11-14 May suggests that weight loss programmes targeting a particular % of weight loss often fail and that other factors should be considered. Read more: easo.org/weight-loss-ta… Obesity Canada

Michael Albert, MD Beverly G. Tchang, MD Karl Nadolsky Dr. Spencer Nadolsky Neil Floch MD Angela Fitch,MD The Lancet Bariatric Times Bariatric News Ricardo Cohen Our data of over 400 patients with BMI > 70: ✴️ 40% weight loss after gastric bypass. ✴️ 30% weight loss after gastric sleeve. ✴️ Durability up to 10 years after bariatric surgery is impressive. ✴️ These people have extremely limited options to help them lose weight.

🚨 New data drop: GLP-1s are shrinking more than waistlines—they're reshaping the grocery cart. - - - A large consumer survey (n=1955) just revealed how GLP-1 meds like Wegovy and Zepbound are disrupting diets—and potentially the entire food industry. ⬇️ Key survey takeaways

ICYMI 🚨 Senate Judiciary Committee Hearing On Pharmacy Benefit Managers "[The big 3 PBMs] engage in self-dealing to steer patients to a PBM’s preferred pharmacy and they squeeze out small, rural pharmacies—not just in Iowa, but in Illinois too—with lowball payments. PBMs also

Retrospective claims data reveals over 20 % of GLP-1 medicine users had nutritional deficiencies diagnosed within one-year of starting GLP-1RA treatment. pdf.sciencedirectassets.com/780950/1-s2.0-…

This is a fantastic study W. Scott Butsch, MD MSc! 👉sciencedirect.com/science/articl… Whether #GLP1s cause micronutrient deficiencies is a hard question to answer with real world data because access to multivitamin/supplements is so easy The gold ⭐️ in this retrospective analysis is actually *Table

💉 GLP-1 meds don’t just curb appetite—sometimes they curb essential nutrients too. - - - 📉 In a study of 460,000+ adults on GLP-1s (mostly with T2D): 🔹13% developed nutritional deficiencies in 6 months 🔹22% within 12 months 🔹Vitamin D deficiency was most common (13.6%) 🔹3%